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Summary
Gilles de la Tourette syndrome is a neuropsychiatric dis-
order characterized by waxing and waning multiple mo-
tor and phonic tics with a complex mode of inheritance.
Previous attempts, which used large multigenerational
families to localize susceptibility loci, have been unsuc-
cessful. In this report, the results of the first systematic
genome scan, using 76 affected-sib-pair families with a
total of 110 sib pairs, are summarized. While no results
reached acceptable statistical significance, themultipoint
maximum-likelihood scores (MLS) for two regions (4q
and 8p) were suggestive (MLS 1 2.0). Four additional
genomic regions also gave multipoint MLS scores be-
tween 1.0 and 2.0.
Introduction
Gilles de la Tourette syndrome (GTS) (MIM 137580) is
a chronic neuropsychiatric disorder with onset in child-
hood. It is characterized by multiple, fluctuating motor
and vocal tics of variable severity. Prevalence estimates
are higher in males than in females, and range from 1/
20,000 to 1/2,000, depending on the age group studied
and on the diagnostic inclusion criteria (Apter et al.
1993). More recent studies in school-age populations
suggest that the prevalence may be somewhat higher
(e.g., 1% in males) (Robertson and Stern 1998). Support
for a genetic component in the etiology of GTS comes
from several lines of evidence, including twin studies
(Price et al. 1985; Hyde et al. 1992) and family studies
(Pauls et al. 1991). Family studies also provide support
for a common genetic basis for GTS, chronic tic disorder
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(CT), and obsessive-compulsive disorder (OCD) (Pauls
et al. 1986). In addition, a relationship with other psy-
chiatric disorders has been suggested (Comings and
Comings 1985). While the relationship between GTS
and other conditions has been somewhat controversial,
the recurrence risk for GTS among first-degree relatives
appears to be quite consistent among studies. Pauls et
al. (1991) reported a recurrence risk for GTS of 7/61
(11.5%) in brothers and 4/83 (4.8%) in sisters of pro-
bands. Walkup et al. (1996) and Hebebrand et al. (1997)
observed recurrence risks that were not significantly dif-
ferent from those reported by Pauls and colleagues.
Segregation analysis generally supports the presence
of a major locus, but the characteristics for this predis-
posing gene vary. Pauls et al. (1990) reported that the
pattern of transmission was consistent with autosomal
dominant inheritance with incomplete penetrance,
whereas Hasstedt and colleagues (1995) found the pat-
tern in large multigenerational families in which there
was bilineal transmission to be consistent with a genetic
model in which the penetrance of the heterozygote was
between the penetrance of the two homozygotes.
Walkup et al. (1996) reported a similar solution but with
a significant multifactorial background. Several studies
have reported the frequent occurrence of bilineal fami-
lies, in which either GTS, CT, or OCD occurs in both
parents of a proband or in one of the parents’ first-degree
relatives (McMahon et al. 1992; Kurlan et al. 1994;
McMahon et al. 1996; Walkup et al. 1996).
Attempts to localize the responsible gene(s) have not
yielded consistent results thus far. Linkage analysis of
data from a series of multiply affected families resulted
in the exclusion of ∼80% of the genome (for review, see
Barr and Sandor 1998). These analyses were completed
assuming a dominant mode of inheritance and locus ho-
mogeneity for GTS and spectrum disorders. This data
set included several very large families, which, on their
own, could yield significant evidence for linkage (Heu-
tink et al. 1995). It is possible that incorrect specification
of genetic parameters (e.g., penetrance and gene fre-
quency) of the GTS susceptibility gene could have led
to false exclusion of one or more relevant genomic
regions.
More recently a genome scan was completed on a
series of multigenerational families (Barr et al. [1999])
that included two families that had also been examined
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by Heutink et al. (1995). This genome scan used more
informative markers that were evenly spaced throughout
the genome. The data were analyzed using both para-
metric (autosomal dominant with reduced penetrance)
and nonparametric methods. LOD scores 11.0, calcu-
lated with the parametric method, were observed for 24
of the markers in at least one of the families. No LOD
scores 12.0 were observed. When the Affected Pedigree
Method (APM; Weeks and Lange 1988) modified by
Ward (1993) was used, eight markers were observed
with a in at least one of the families. APMP ! .00005
has been shown to be more likely to give false positive
results (Field and Kaplan 1998), so these results should
be interpreted with caution.
Other approaches have also been employed in the
search for GTS-susceptibility loci. Several families have
been reported with apparent cosegregation of balanced
translocations with GTS (for a review, see Robertson
and Boardman 1996), but these candidate regions have
not been supported by positive linkage findings in other
families (Heutink et al. 1990). In addition, a number of
association studies have been published examining a va-
riety of candidate genes in GTS patients and controls
(Comings et al. 1991; Comings et al. 1993; No¨then et
al. 1994a, 1994b; Grice et al. 1996). Finally, Simonic
and colleagues (1998) performed a genomewide search
(with genetic markers at an average spacing of 3 cM)
using a case-control strategy in a sample of unrelated
patients with GTS from an Afrikaner population. These
investigators reported positive associations betweenGTS
and markers on chromosomes 11, 14, 20, and 21 that
were highly significant before correction for multiple
testing. While these are potentially interesting leads, as-
sociation studies should be interpreted with caution. It
has been demonstrated that false positive findings can
occur when controls are not perfectly matched with re-
spect to their genetic background (Kidd 1993). It should
be noted that none of the positive reports from associ-
ation studies have been replicated.
Analysis of affected sib pairs has been proposed as an
alternative to parametric linkage analysis and associa-
tion studies. The sib-pair approach is suited for diseases
with an unclear mode of inheritance and has been used
successfully in studies of other complex disorders. Thus,
given the lack of conclusive results frommore traditional
linkage and association studies, an affected-sib-pair
study appears to be an appropriate strategy to identify
chromosomal regions linked to GTS.
The overall contribution of genetic factors to disease
susceptibility can be measured conveniently by compar-
ing the risks for various types of relatives of probands
with the risk of the disease in the general population
(Risch 1990a). When calculated in this way, the relative
risk for sibs of GTS probands is sufficiently high (lsib 1
10.0) to suggest that affected sib-pair analysis is a viable
alternative to traditional parametric linkage analysis for
GTS. In this report, the results of a complete genome
screen using 370 highly polymorphic DNA markers is
reported. The sample for this genome scan consisted of
76 affected-sib-pair families with at least one parent
available for clinical evaluation and genotyping. These
76 families yielded a total of 110 sib pairs. Correcting
for nonindependence resulted in a sample that was
equivalent to 91 independent pairs.
Material and Methods
Sample
All affected-sib-pair families consisted of at least two
sibs affected with GTS. Furthermore, in the ascertain-
ment of families, if both parents were affected with GTS
or if one parent had GTS, CT, OCD, and/or subclinical
OCD and the other parent also received a diagnosis of
CT, OCD, and/or subclinical OCD the family was not
included in the analyses reported here. All diagnoses
were made using DSM-III-R criteria. The criteria for
subclinical OCD were the same as those used to make
a diagnosis of OCD, with the exception that the indi-
vidual did not perform the compulsions or obsessions
for at least an hour, did not experience them as ego-
dystonic, or did not report any impairment. These were
the same criteria used in the family study of OCD re-
ported by Pauls et al. (1995). The final sample included
in the genome scan consisted of 76 families with at least
two sibs affected with GTS. Both parents were included
in the tests for 72 families. Among these 72 families,
there were 19 in which neither parent was affected with
GTS, tics, or OCD; 32 in which the father was affected
and the mother was unaffected; and 21 in which the
mother was affected and the father was unaffected. In
the remaining four families, only one parent was tested;
in every case that parent was unaffected. Of the 76 fam-
ilies, 64 had only two children who were affected, 10
had three affected sibs, and the remaining 2 had four
and five affected sibs, respectively.
Phenotypic Evaluation
When a family entered the study, information con-
cerning both affected siblings and their parents was col-
lected in a two-stage process. The initial stage consisted
of the collection of information concerning symptoms
associated with GTS and OCD using a self-and-family
report based on the tic inventory and ordinal severity
scales of the Yale Global Tic Severity Scale (Leckman et
al. 1989) and the symptom checklist and ordinal scales
of the Yale-Brown Obsessive-Compulsive Scale (Good-
man et al. 1989). Earlier versions of these instruments
have been used in prior studies of individuals with GTS
and OCD and have been shown to have a high level of
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agreement with expert clinician ratings of tic and ob-
sessive-compulsive symptom severity (Leckman et al.
1993, 1994, 1997). In a second stage, the validity of
these symptom ratings were reviewed by an experienced
clinician to insure their accuracy and validity. These in-
struments are currently being used in family studies of
both GTS and OCD. Earlier versions have been shown
to be both valid, when compared to clinician diagnoses
(the rates of agreement between interview derived di-
agnoses and clinical diagnoses were .98 for GTS and .97
for OCD), and reliable, for the diagnoses of GTS (k =
) and OCD ( ) (Pauls et al. 1995). For the1.00 k = .97
assessment of other psychopathology, the Kiddie Sched-
ule for Affective Disorders and Schizophrenia (Cham-
bers et al. 1985; Kaufman et al. 1995) was used for
children aged !18 years and the Structured Clinical In-
terview for DSM-III-R (Spitzer et al. 1992) was used for
adults. Both interviews have established reliability. For
this report, only sibs with a diagnosis of GTS were con-
sidered to be affected. Future analyses will include in-
formation about chronic tics, OCD, attention deficit hy-
peractivity disorder, and other comorbid conditions.
Best-Estimate Diagnoses
All diagnoses were made using the best-estimate ap-
proach (Leckman et al. 1982). The best-estimate pro-
cedure used in the present study followed a standard
protocol. Before the initial diagnostic estimate was
made, separate files for each individual were prepared.
These files contained all available information about the
individual, including the completed interview packet and
medical records, when available. All of this information
was reviewed by three clinicians (B. v.d.W., Rotterdam
site; W. M., Utah site; R. A. K., Yale site) who indepen-
dently made diagnostic assessments. All three diagnos-
ticians were blind to the prior diagnosis of the individual
and to his/her relationship to the proband. Each inter-
view was evaluated by two raters. The best estimates of
the two diagnosticians were then compared. The rate of
agreement between any two diagnosticians was very
high ( ) for the diagnosis of GTS. When there wask = .97
disagreement between the two raters, the individual files
were reviewed by the third diagnostician and a final
consensus diagnosis was assigned. These consensus di-
agnoses were then compared with the diagnosis assigned
by the clinician at the site where the family was recruited.
If there were differences, the clinical materials were re-
viewed via a conference call and consensus was reached
if possible. If there was still disagreement, more data
were requested to help resolve the differences. If there
was still disagreement, the family was removed from the
sample. For the current report, only diagnoses of GTS,
chronic tics, OCD, and ADHD were made.
DNA Markers
Short tandem-repeat polymorphisms (STRPs) from
Marshfield Screening Set 8 (Yuan et al. 1997) were gen-
otyped in Marshfield. The markers chosen were at a 10-
cM average density.
Data Analysis
Allele frequencies for the genetic markers were estab-
lished by gene counting in genotyped parents. Tests for
linkage were done under the direction of LS (Rotterdam
site) and were performed following the maximum-like-
lihood–score (MLS) approach (Risch 1990b). In general,
the MLS does not depend on marker allele frequencies
when the parents’ genotypes are available, which was
the case for almost all families in the present study. For
each pair of affected sibs, the identity-by-descent (IBD)
distribution was estimated by single-point and multi-
point analysis. In the single-point analysis, the IBD dis-
tribution was estimated given the marker genotypes for
each marker individually. In the multipoint analysis,
MLS values were computed for 14,000 different loca-
tions relative to the markers (average step size !1 cM).
For all calculations the MAPMAKER-SIBS program
(Kruglyak and Lander 1995) was used. In the estimation
of the IBD distribution, this program only considers IBD
vectors that are biologically consistent, lying within the
“possible triangle” as described by Holmans (1993). All
MLS calculations allowed for dominance variance. In
addition to theseMLS calculations, the information con-
tent of the marker map was evaluated, and likelihoods
were calculated for a fixed value of ls of 2.0 under the
assumption of no dominance variance, which leads to
an IBD vector of . A com-(z , z , z ) = (.125, .5, .375)0 1 2
parison of these likelihoods with the likelihoods ob-
tained for the Mendelian expectation (z , z , z ) =0 1 2
yields exclusion LOD scores for a GTS-(.25, .5, .25)
predisposing gene with a (Kruglyak and Landerl = 2sib
1995).
For families with more than two affected siblings, all
possible pairs were evaluated, and the results were
weighted by a factor equal to 2/n, where n indicates the
number of affected children in the sibship.
Results
As noted above, the 76 families yielded a total of 110
sib pairs. Weighting by a factor of 2/n resulted in a
sample equivalent to 91 independent sib pairs. The
power of this sample is sufficient to detect linkage when
lsib is 4. When equations published by Risch and Mer-
ikangas (1996) are used, this sample of 91 sib pairs has
power of 59% to map a given locus with , andl = 2sib
99.9% when .l = 4sib
The panel of markers genotyped included 370 DNA
TSA International Consortium for Genetics: Genome Scan of GTS 1431
markers with an average spacing of 9.1 cM in the male
meiotic map. The observed average heterozygosity of
this set of markers was .77. Single-point analyses with
dominance variance yielded MLS values of 2.38 and
2.09, respectively, for markers D4S1625 and D8S1106.
Twelve additional markers (D1S1728, D4S403,
D4S2623, D4S1644, D6S1053, D8S1130, D8S1145,
D8S136, D10S1213, D11S912, D14S592, and
D17S1298) yielded MLS values between 1.0 and 2.0.
Two of these markers (D4S2623 and D4S1644) are lo-
cated in the vicinity of D4S1625, and three (D8S1130,
D8S1145, and D8S136) are in the vicinity of D8S1106.
Graphs of multipoint MLS values are shown infigure 1.
Two regions show suggestive MLS values 2.0. On
chromosome 4, MLS values exceeded 2.0 over a region
of ∼12 cM, including markers D4S1644 and D4S1625,
with a peak MLS value of 2.3 at ∼3 cM telomeric of
D4S1625. The estimated IBD values at this locationwere
. On chromosome 8,(z , z , z ) = (.185, .370, .445)0 1 2
MLS values reached 2.0 in two adjacent intervals,
bounded by markers D8S1106, D8S1145, and D8S136,
respectively. Here the estimated IBD values were
. As can be seen in figure(z , z , z ) = (.146, .442, .412)0 1 2
1, four additional regions show multipoint MLS values
11.0. These regions are on chromosomes 1, 10, 13, and
19. Finally, summing over all regions for which the LOD
score was !2.0 suggests that ∼35% of the genome has
been excluded, assuming .l = 2sib
Discussion
When judged purely on the basis of twin and family
studies (Price et al. 1985; Pauls et al. 1991; Hyde et al.
1992; Hebebrand et al. 1997), the evidence for a sub-
stantial genetic contribution to the etiology of GTS is
convincing. Even when the highest estimates for the pop-
ulation prevalence of GTS are considered, the risk for
first-degree relatives of probands is increased by at least
a factor of 10. Thus, it is surprising that genetic linkage
studies have so far been unsuccessful. It is possible that
such an increased risk in close relatives of probands
could be due to shared environmental factors. If such
factors exist, the outlook for their detection is much
better than that for the detection of similar factors in
some late-onset diseases, such as multiple sclerosis, be-
cause the time window, between birth and onset of dis-
ease, for such factors to act would be quite small. That
no clear risk factors have yet been identified in the fa-
milial shared environment is in agreement with the re-
sults of segregation analysis. To date, all segregation
analyses for GTS consistently yield evidence that the risk
for GTS is transmitted in a Mendelian fashion and that
there are genes of major effect that contribute to its
manifestation (Pauls et al. 1990; Hasstedt et al. 1995;
Walkup et al. 1996).
The results of segregation analysis are also consistent
with the observed high relative risks for close relatives
of probands. Given these high relative risks, many in-
vestigators believed that it should be relatively simple to
map the gene(s) responsible for GTS in one or a few
large multiply affected families. These efforts have not
resulted in convincing linkage findings, even when the
existing large families were considered separately (Heu-
tink et al. 1995; Barr et al. [1999]). It is conceivable that
extensive locus heterogeneity might preclude one from
detecting linkage in a series of unrelated families. In that
case, however, one would expect to find suggestions for
linkage in the existing large families, albeit for each fam-
ily in a different location. It is noteworthy that Barr and
colleagues (1999) did observe suggestive evidence for
regions on chromosomes 5 and 19p.
One potential pitfall in the study of large families has
been discussed (Pauls 1993): the very unpredictable and
highly biased ascertainment procedure that leads to the
identification of large multiply affected families may lead
to identification of families segregating for more than a
single disease gene, even when those disease genes are
rare in the general population. A general problem in the
early statistical analyses of linkage in family data was
the choice of genetic model parameters—most impor-
tantly, the gene frequency and the penetrances for the
different genotypes. Serious misspecification of these pa-
rameters may lead to false exclusion of the region of
interest (Heutink et al. 1995). Furthermore, it is not
appropriate to rely completely on the results of segre-
gation analysis for this purpose. When locus heteroge-
neity exists, and some loci act recessively while others
act dominantly, the joint segregation analysis of these
families may yield intermediate results that are inade-
quate for analysis of linkage in each individual family.
The models chosen in earlier mapping efforts were
broadly in agreement with the results of segregation
analysis and family studies: dominant, with a low gene
frequency and a relatively low phenocopy frequency,
leading to a high recurrence risk in families.
Given that the early mapping studies were inconclu-
sive, a new series of families with sib pairs affected with
GTS were ascertained for a complete genome scan. It
should be emphasized that all affected sibs met diag-
nostic criteria for GTS. That is, in contrast to linkage
studies in large families, no relatives with CT or OCD
were considered as affected in the sib pairs. Furthermore,
all linkage analyses were done using nonparametric
methods.
Two areas, one on chromosome 4q and another on
chromosome 8p, are suggestive of linkage. When viewed
from a pessimistic standpoint, the results are disappoint-
ing, in that no single area of the genome showed sig-
nificantly increased IBD sharing in the affected siblings.
It is possible that the increased allele sharing in either
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of these regions is only due to chance. On the other hand,
these peaks in the MLS curve may reveal the true lo-
cation of genetic risk factors for GTS. Certainly, these
results suggest that additional typings are needed in these
areas, as well as in the other regions of the genome in
which there are suggestive MLS scores (i.e., 1.0 !
). At present, additional genotyping is underMLS ! 2.0
way in the available multigenerational families and will
be completed in new affected-sib-pair families that are
currently being evaluated. It should be recognized that
if these peaks represent real genetic risk factors, it is
likely that they only convey mildly increased risks.
It is clear that for further analysis of these regions in
the available extended families, nonparametric methods
should be employed. Given the relative risks of these
loci, it is unlikely that the appropriate geneticmechanism
could be adequately modeled. In this respect, it is im-
portant to observe that the sharing pattern observed for
4q is most consistent with a recessive contribution in
this region: the increased sharing is exclusively based on
an excess of affected sib pairs sharing two parental al-
leles. On the basis of the ascertainment procedures fol-
lowed in the collection of the existing series of extended
families, it is unlikely that a recessively acting gene
would play a prominent role in those families, although
in several of the large families there is evidence for bil-
ineal inheritance of milder forms of the syndrome (i.e.,
CT and/or OCD). At the present time, there is no way
of knowing whether the locus on 4q contributes to the
expression of CT and/or OCD. Therefore, further anal-
ysis of this region should be mostly based on findings
in additional sib pairs affected with GTS.
It is important to note that the sharing pattern for 8p
is most consistent with a dominant contribution in this
region. That is, the increased sharing comes from sib
pairs sharing just one parental allele. This is also gen-
erally true for the other four genomic regions that have
multipoint MLS scores greater than 1.0. Thus, the ex-
isting large families should be helpful in understanding
more completely the genetic mechanisms in these areas.
Nevertheless, more affected sib pairs are needed to fol-
low up these results as well.
It is somewhat disappointing that none of the several
chromosomal regions (e.g., 3 [3p21.3], 8 [8q21.4], 9
[9pter], and 18 [18q22.3]) in which there were cyto-
genetic abnormalities cosegregating with GTS and re-
lated conditions showed any strong evidence for linkage
in these families. Furthermore, none of the regions in
which associations had been reported with candidate
genes are supported by these results (e.g., DRD2 [11q22]
and DRD4 [11p15]). It is still possible that there are
genetic loci in the regions identified by the cytogenetic
abnormalities that confer some risk for GTS and related
conditions and that the reason that they were not seen
in the current study is that only GTS was examined. If
that is the case, then it could be concluded that the
cytogenetic abnormalities are more likely to be associ-
ated with the related conditions and that the GTS seen
in these families could be etiologically different than that
observed in these sib-pair families.
It is noteworthy that one region that has been sug-
gested from a genome scan of multigenerational families
(chromosome 19p; Barr et al. [1999]) is also positive in
the current study. Clearly, this and the other positive
regions need to be explored more thoroughly to deter-
mine whether these findings represent true linkages.
In sum, the results of the first systematic genomewide
scan for GTS suggest that there are several genes of
moderate effect that increase susceptibility to GTS. Fur-
ther work is needed to confirm and extend these findings.
While it is possible that the current results are false pos-
itives, they represent the best available data as to the
location of susceptibility loci for this complex neuro-
psychiatric disorder of children and adults.
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